Here are the news briefs for March 21, 2018:
Delta 9 Cannabis Inc.
Delta 9 Cannabis (TSXV: NINE) signed a binding letter of intent and a lease agreement with 6599362 Canada Ltd. for the land and building containing the company’s current cannabis production facility or “Building E”. The new lease also contains an option for Delta 9 to purchase Building E for a price of $6.25 million at any time during the term of the new lease. The company anticipates executing this option to purchase Building E within the next few days.
WeedMD (WDDMF) announced that it made a strategic investment in Snipp Interactive Inc. (SPN.V), a global loyalty and promotions company focused on disruptive engagement platforms for consumers. The companies have also entered into an agreement whereby WeedMD will appoint Snipp as its technology vendor of record to design and deploy custom marketing solutions for direct sales, retail sales, referral/sourcing programs, distributor programs and other programs.
Nemus Bioscience, Inc.
Cannabinoid biotech firm Nemus Bioscience (NMUS) named Professor David Schubert, Laboratory Head of the Salk Institute’s Cellular Neurobiology Laboratory to its Scientific Advisory Board.
Dr. Schubert is a two-time recipient of the Jacob Javits Award for outstanding contributions to neuroscience from the National Institute of Neurological Disorders and Stroke (NINDS), a section of the National Institutes of Health (NIH).